The European Medicines Agency (EMA) is organising this webinar to provide an in-depth overview of the Clinical Trials Information System (CTIS), its optimisations, best practices, and upcoming developments.
Online
European Medicines Agency, Amsterdam, the Netherlands
Live broadcast
Data początkowa:
22 Maj 2025, 12:30 (CEST)
Data końcowa:
22 Maj 2025, 17:30 (CEST)
EventHumanCorporateClinical trials
Online
European Medicines Agency, Amsterdam, the Netherlands
Data początkowa:
21 Maj 2025, 10:00 (CEST)
Data końcowa:
21 Maj 2025, 11:30 (CEST)
EventHumanMedicine shortagesMedicines
Online
European Medicines Agency, Amsterdam, the Netherlands
Live broadcast
Data początkowa:
21 Maj 2025, 09:00 (CEST)
Data końcowa:
21 Maj 2025, 17:30 (CEST)
EventHumanVeterinary
Online
European Medicines Agency, Amsterdam, the Netherlands
Data początkowa:
20 Maj 2025, 14:00 (CEST)
Data końcowa:
20 Maj 2025, 16:30 (CEST)
EventHuman
Online
European Medicines Agency, Amsterdam, the Netherlands
Data początkowa:
20 Maj 2025
Data końcowa:
23 Maj 2025
EventHumanPaediatrics
Online
European Medicines Agency, Amsterdam, the Netherlands
Live broadcast
Data początkowa:
19 Maj 2025, 15:00 (CEST)
Data końcowa:
19 Maj 2025, 16:00 (CEST)
EventHumanData on medicines
European Medicines Agency, Amsterdam, the Netherlands
Data początkowa:
19 Maj 2025
Data końcowa:
22 Maj 2025
EventHumanMedicines
European Medicines Agency, Amsterdam, the Netherlands
Data początkowa:
14 Maj 2025, 17:00 (CEST)
Data końcowa:
14 Maj 2025, 19:00 (CEST)
EventVeterinary
This Walk-in clinic on CTIS functionalities provides an opportunity for sponsors to receive practical information about the Clinical Trials Information System by asking questions to CTIS experts in real time.
Online
European Medicines Agency, Amsterdam, the Netherlands
Live broadcast
Data początkowa:
14 Maj 2025, 16:00 (CEST)
Data końcowa:
14 Maj 2025, 17:00 (CEST)
EventHumanClinical trialsMedicines
European Medicines Agency, Amsterdam, the Netherlands
Data początkowa:
14 Maj 2025
Data końcowa:
16 Maj 2025
EventHumanAdvanced therapiesInnovation